Respiratory Syncytial Virus (RSV)

Respiratory Syncytial Virus (RSV)

Latest Posts

In 2023-24, RSV vaccines were 79% effective against virus-related blood clots in older adults, CDC estimates​
CDC reports 6 more child deaths from flu, as virus levels stay moderate to high​
Study ties adult RSV hospitalization to a higher risk of heart and lung problems in next 6 months​
Analysis suggests nirsevimab cuts infant RSV hospitalizations 83%​
Most Americans would recommend RSV immunizations for older adults, infants, pregnant women​
Universal nirsevimab slashes RSV infant hospitalizations, study suggests​
Pfizer’s RSV vaccine safe to use during pregnancy, study suggests​
Studies: RSV prevention strategies—especially nirsevimab—may cut infant hospitalizations​
RSV confers similar risk of poor outcomes in hospitalized patients as flu over time, data suggest​
Nirsevimab may help prevent severe respiratory illnesses beyond RSV in infants, young kids​
RSV options: Most pregnant women, parents prefer the maternal RSV vaccine over the infant antibody shot​
Study details full range of what respiratory virus infections look like in young kids​
Asthma, chronic kidney disease and other high-risk conditions increase the risk for severe RSV illness​
Point-of-care respiratory virus testing in nursing homes could prevent hospital transfers​
Getting the RSV vaccine during pregnancy is a game-changer for infant hospitalizations​
CIDRAP Op-Ed: RSV—the middle child of respiratory season who deserves more attention​
Nirsevimab monoclonal antibody for RSV well tolerated in infants, study suggests​
Only 6 symptoms, conditions appear unique to long COVID, suggesting overlap with other post-viral infections​
RSV tied to high complication, death rates in hospitalized older adults​
Quick takes: Re-emergent COVID strain, extended US RSV season, typhus in California​